Science
Take-away diagnostics: Delivering the future?
After a rise in at-home tests and a fall in non-COVID-related hospital attendances during the pandemic, will a new era of diagnostics be ushered in as we return to normality? We look at the evidence.
News
-
“Tumour-uninformed” blood test
A team of scientists has evaluated the first “tumour-uninformed” test that detects cancer DNA circulating in the blood of patients following treatment.
Haematology & Transfusion Science -
Ultrasonically oscillating biopsy needles
Modifying a biopsy needle to vibrate rapidly at 30,000 times per second improves yields and could mean potentially a less painful experience for patients.
Haematology & Transfusion Science -
All-in-one Covid surveillance test
A new type of COVID-19 testing strategy could help streamline the process of identifying cases, tracking variants and detecting co-infecting viruses, it is claimed.
Microbiology & Virology
Science
Unintended consequences
Computational biologist Gregorio Alanis- Lobato highlights the need for greater awareness of and further research into the effects of CRISPR-Cas9 genome editing.
The big question: multidisciplinary working
This month we ask: “What is the future of multidisciplinary working?”
The evolution of quality assessment
In 2011, UK NEQAS Cellular Pathology Technique (CPT) carried out tests across four schemes – it now covers 12 schemes with two in the pipeline. We hear from Chantell Hodgson, UK NEQAS CPT Scheme Manager.
Latest Jobs
IBMS Twitter
Resources
Here to help: The law of the vital few
Alan Wainwright, IBMS Executive Head of Education, on the Specialist Portfolio Examiner shortage.
